Characterization of fibroblast growth factor 1 in obese children and adolescents

Background: Fibroblast growth factor 1 (FGF1) can regulate glucose and lipid metabolism in obese mice. Serum FGF1 has increased in type 2 diabetes mellitus adults and correlated with BMI. This study aimed to indicate conventional weight loss effects on FGF1 in obese children and adolescents. Materi...

Full description

Bibliographic Details
Main Authors: Anru Wang, Xueqin Yan, Cai Zhang, Caiqi Du, Wenjun Long, Di Zhan, Xiaoping Luo
Format: Article
Language:English
Published: Bioscientifica 2018-09-01
Series:Endocrine Connections
Subjects:
Online Access:https://ec.bioscientifica.com/view/journals/ec/7/8/EC-18-0141.xml
id doaj-bec740a50bc6450e9f694909baeaae5e
record_format Article
spelling doaj-bec740a50bc6450e9f694909baeaae5e2020-11-25T00:39:16ZengBioscientificaEndocrine Connections2049-36142049-36142018-09-0178932940https://doi.org/10.1530/EC-18-0141Characterization of fibroblast growth factor 1 in obese children and adolescentsAnru Wang0Xueqin Yan1Cai Zhang2Caiqi Du3Wenjun Long4Di Zhan5Xiaoping Luo6Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Department of Pediatrics, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Pediatrics, Boai Hospital of Zhongshan, Zhongshan, ChinaDepartment of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaBackground: Fibroblast growth factor 1 (FGF1) can regulate glucose and lipid metabolism in obese mice. Serum FGF1 has increased in type 2 diabetes mellitus adults and correlated with BMI. This study aimed to indicate conventional weight loss effects on FGF1 in obese children and adolescents. Materials and methods: Clinical and metabolic parameters of 88 lean and obese individuals (ages 5–15 years) and 39 obese individuals followed with 6 months of lifestyle intervention were collected. Serum FGF1 levels were detected through enzyme-linked immunosorbent assays. Results: FGF1 levels were increased in obese individuals. Serum FGF1 levels were significantly correlated with BMI and waist circumferences (r = 0.377, P = 0.012; r = 0.301, P = 0.047, respectively). Multivariate stepwise linear regression analyses showed that FGF1 levels were significantly correlated with HbA1c and HOMA-IR (β = 0.371, P = 0.008; β = 0.323, P = 0.021, respectively). Weight loss (2.3 ± 0.1 kg) was accompanied by a significant reduction of circulating FGF1 levels (7.2 ± 0.4 pg/mL). Changes in FGF1 were significantly correlated with changes in fasting glucose, HOMA-IR and low-density lipoprotein cholesterol (β = 0.277, P = 0.020; β = 0.474, P < 0.001; β = 0.320, P = 0.008, respectively). Conclusion: FGF1 was related to increased risk of insulin resistance in obese children and adolescents. Serum FGF1 reduced after weight loss in obese individuals and was associated with the improvement of insulin resistance. Changes in serum FGF1 were more correlated with insulin resistance than changes in obesity per se.https://ec.bioscientifica.com/view/journals/ec/7/8/EC-18-0141.xmlfibroblast growth factor 1weight losschildren and adolescentsobesity
collection DOAJ
language English
format Article
sources DOAJ
author Anru Wang
Xueqin Yan
Cai Zhang
Caiqi Du
Wenjun Long
Di Zhan
Xiaoping Luo
spellingShingle Anru Wang
Xueqin Yan
Cai Zhang
Caiqi Du
Wenjun Long
Di Zhan
Xiaoping Luo
Characterization of fibroblast growth factor 1 in obese children and adolescents
Endocrine Connections
fibroblast growth factor 1
weight loss
children and adolescents
obesity
author_facet Anru Wang
Xueqin Yan
Cai Zhang
Caiqi Du
Wenjun Long
Di Zhan
Xiaoping Luo
author_sort Anru Wang
title Characterization of fibroblast growth factor 1 in obese children and adolescents
title_short Characterization of fibroblast growth factor 1 in obese children and adolescents
title_full Characterization of fibroblast growth factor 1 in obese children and adolescents
title_fullStr Characterization of fibroblast growth factor 1 in obese children and adolescents
title_full_unstemmed Characterization of fibroblast growth factor 1 in obese children and adolescents
title_sort characterization of fibroblast growth factor 1 in obese children and adolescents
publisher Bioscientifica
series Endocrine Connections
issn 2049-3614
2049-3614
publishDate 2018-09-01
description Background: Fibroblast growth factor 1 (FGF1) can regulate glucose and lipid metabolism in obese mice. Serum FGF1 has increased in type 2 diabetes mellitus adults and correlated with BMI. This study aimed to indicate conventional weight loss effects on FGF1 in obese children and adolescents. Materials and methods: Clinical and metabolic parameters of 88 lean and obese individuals (ages 5–15 years) and 39 obese individuals followed with 6 months of lifestyle intervention were collected. Serum FGF1 levels were detected through enzyme-linked immunosorbent assays. Results: FGF1 levels were increased in obese individuals. Serum FGF1 levels were significantly correlated with BMI and waist circumferences (r = 0.377, P = 0.012; r = 0.301, P = 0.047, respectively). Multivariate stepwise linear regression analyses showed that FGF1 levels were significantly correlated with HbA1c and HOMA-IR (β = 0.371, P = 0.008; β = 0.323, P = 0.021, respectively). Weight loss (2.3 ± 0.1 kg) was accompanied by a significant reduction of circulating FGF1 levels (7.2 ± 0.4 pg/mL). Changes in FGF1 were significantly correlated with changes in fasting glucose, HOMA-IR and low-density lipoprotein cholesterol (β = 0.277, P = 0.020; β = 0.474, P < 0.001; β = 0.320, P = 0.008, respectively). Conclusion: FGF1 was related to increased risk of insulin resistance in obese children and adolescents. Serum FGF1 reduced after weight loss in obese individuals and was associated with the improvement of insulin resistance. Changes in serum FGF1 were more correlated with insulin resistance than changes in obesity per se.
topic fibroblast growth factor 1
weight loss
children and adolescents
obesity
url https://ec.bioscientifica.com/view/journals/ec/7/8/EC-18-0141.xml
work_keys_str_mv AT anruwang characterizationoffibroblastgrowthfactor1inobesechildrenandadolescents
AT xueqinyan characterizationoffibroblastgrowthfactor1inobesechildrenandadolescents
AT caizhang characterizationoffibroblastgrowthfactor1inobesechildrenandadolescents
AT caiqidu characterizationoffibroblastgrowthfactor1inobesechildrenandadolescents
AT wenjunlong characterizationoffibroblastgrowthfactor1inobesechildrenandadolescents
AT dizhan characterizationoffibroblastgrowthfactor1inobesechildrenandadolescents
AT xiaopingluo characterizationoffibroblastgrowthfactor1inobesechildrenandadolescents
_version_ 1725294270123868160